Skip to main content
Have a personal or library account? Click to login
Change of TGF-β1 concentration in blood serum of patients during systemic treatment of severe psoriasis Cover

Change of TGF-β1 concentration in blood serum of patients during systemic treatment of severe psoriasis

Open Access
|Feb 2012

References

  1. Ahmad Fadzil, M.H., Ihtatho, D., Affandi, A.M., Hussein, S.H. (2008). Objective assessment of psoriasis erythema for PASI scoring.. IEEE Engineering in Medicine and Biology Society, pp. 4070-4073.
  2. Arsura, M., Wu, M., Sonenshein, G.E. (1996). TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha.,, 31-40.
  3. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A.A., Rojkind, M. Bottinger, E.P. (2000) A mechanism of suppression of TGF-β/SMAD signalling by NF-κB/Rela.,, 187-197.
  4. Caserta, T.M., Knisley, A.A., Tan, F.K., Arnett, F.C., Brown, T.L. (2004). Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome.,(4), 359-363.
  5. Chen, L.Z., Hochwald, G.M., Huang, C., Dakin, G., Tao, H., Cheng, C. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.,, 12516-12521.
  6. Cueller, M.L., Espinoza L.R. (1997). Methotrexate use in psoriasis and psoriatic arthritis.,, 797-809.
  7. Dahler, A.L., Cavanagh, L.L., Saunders, N.A. (2001). Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways.,(2), 266-274.
  8. De Jong, R., R.AW., van Lier, F.W., Ruscetti, C., Schmitt, P., Debre, M.D. Mossalayi (1993) Differential effect of transforming growth factor-β1 on the activation of human naive and memory CD4+ T lymphocytes.,, 631-638.
  9. Dennler, S., Goumans, M.-J. Dijke, P. (2002) Transforming growth factor β signal transduction.,, 731-740.
  10. Elder, J.T., Ellingsworth, L.R., Fisher, G.J., Voorhees, J.J. (1990). Transforming growth factor-beta in psoriasis.Ann. NY Acad. Sci.,, 218-230.
  11. Fantini, M.C., Becker, C., Monteleone, G., Pallone, F., Galle, P.R., Neurath, M.F. (2004). Cutting edge, TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.,(9), 5149-5153.
  12. Gamblicher, T., Breuckmann, F., Boms, S. (2005). Narrowband UVB phototherapy in skin conditions beyond psoriasis.,, 1099-1000.
  13. Go, C., Li, P. Wang, X.-J. (1999). Blocking transforming growth factor β signaling in transgenic epidermis accelerates chemical carcinogenesis. A mechanism associated with increased angiogenesis.,, 2861-2868.
  14. Gray, J.D., Hirokawa, M., Horwitz, D.A. (1994). The role of transforming growth factor β in the generation of suppression, an interaction between CD8+ T and NK cells.,, 1937-1942.
  15. Hammad, A.M., Youssef, H.M., El-Arman, M.M. (2006). Transforming growth factor beta 1 in children with systemic lupus erythematosus, a possible relation with clinical presentation of lupus nephritis.,(9), 608-612.
  16. Han, K.-H., Choi, H.-R., Won, C.-H., Chung, J-H., Cho, K.-H., Eun, H.-C., Kim, K.-H. (2005). Alteration of the TGF-β/SMAD pathway in intrinsically and UV-induced skin aging.,, 560-567.
  17. Hönigsmann, H. (2001). Phototherapy for psoriasis.,, 343-350.
  18. Horwitz, D.A., Gray, D.K. Ohtsuka (1999). Role of NK cells and TGF-β in the regulation of T-cell-dependent antibody production in health and autoimmune disease.,(5), 1305-1311.
  19. Jeffes, E.W., McCullough, J.L., Pittelkow, M.R. (1995). Methotrexate therapy of psoriasis, differential sensitivity of proliferating lymphoid andepithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate.,, 183-188.
  20. Khalil, N. (1999). TGF-beta: From latent to active.,(15), 1255-1263.
  21. Laouar, Y., Sutterwala, F.S., Gorelik, L., Flavell, R.A. (2005). Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ.,, 600-607.
  22. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β (1998).,, 137-161.
  23. Lu, L.-Y., Cheng, H-H, Sung, P.-K., Yeh, J.-J., Shiue, Y.-L., Chen, A. (2004). Single-nucleotide polymorphisms of transforming growth factor-g1 gene in Taiwanese patients with systemic lupus erythematosus. J. Microbiol.,(3), 135-142.
  24. Mahon, B.D., Gordon, S.A., Cruz, J., Cosman, F. Cantorna, M.T. (2003). Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.,, 128-132.
  25. Massague, J. (2000). How cell read TGF-β signals.,, 164-177.
  26. Massague, J. (1990). The transforming growth factor-β family.,, 597-641.
  27. Matsubara, T., Umezawa, Y., Tsuru, S., Motohashi, T., Yabuta, K., Furukawa, S. (1997). Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.,(4), 314-317.
  28. Mauviel, A. (2009). Transforming growth factor-beta signaling in skin: Stromal to epithelial cross-talk.,(1), 7-9.
  29. Mieliauskaite, D., Venalis, P., Dumalakiene, I., Venalis, A., Distler, J. (2009). Relationship between serum levels of TGF-β1 and clinical parameters in patients with rheumatoid arthritis and Sjogren's syndrome secondary to rheumatoid arthritis.,(4), 356-358.
  30. Ohsugi, I., Imamura, O., Satoh, M., Sugawara, M., Goto, M., Sugimoto, M., Furuichi, Y. (2000). Overexpression of mRNAs of TGFβ-1 and related genes in fibroblasts of Werner syndrome patients.,(3), 189-198.
  31. Oyama, N., Iwatsuki, K., Satoh, M., Akiba, H., Kaneko, F. (2000). Dermal fibroblasts are one of the therapeutic targets for topical applicationof 1α, 25 - dihydroxyvitamin D3, the possible involvement of transforming growth factor-β induction.,, 1140-1148.
  32. Pardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., Moustakas, A. (2000). Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.,(38), 29244-29256.
  33. Ravitz, M.J. (1997). Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation.,, 165-207.
  34. Rubtsov, Y.P., Rudensky, A.Y. (2007). TGF beta signalling in control of T-cell-mediated self-reactivity.,(6), 443-453.
  35. Saltis, J. (1996). TGF-beta: Receptors and cell cycle arrest. Mol.,(2), 227-232.
  36. Sellheyer, K., Bickenbach, J.R., Rothnagel, J.A. (1993). Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice.,, 5237-5241.
  37. Shen, L., Smith, J.M., Shen, Z., Eriksson, M., Sentman, C., Wira, C.R. (2007). Inhibition of human neutrophil degranulation by transforming growth factor-beta1.,(1), 155-161.
  38. Su, H., Ye, D.Q., Wang, B.L, Fang, X.H., Chen, J., Wang, Q., Li, W.X., Zhang, N. (2008). Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cellsreverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.,(6), 1197-1209.
  39. Taihao, Q., Tianyuan, H., Sewon, K., Voorhees, J.J., Fisher, G. (2002). Ultraviolet irradiation alters transforming growth factor β/Smad pathway in human skin.,, 499-506.
  40. Ten Dijke, P., Goumans, M.J., Itoh, F., Itoh, S. (2002). Regulation of cell proliferation by Smad proteins.,, 1-16.
  41. Ulloa, L, Doody, J., Massague, J. (1999). Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway.,, 710-713.
  42. Van Ruissen, F., van Erp, P.E., de Jongh, G.J., Boezeman, J.B., van de Kerkhof, P.C., Schalkwijk, J. (1994). Cell kinetic characterization of growth arrest in cultured human keratinocytes,(8), 2219-2228.
  43. Wang, X.-J., Greenhalgh, D.A., Bickenbach, J.R., Jiang, A., Bundman, D.S., Krieg, T., Derynck, R., Roop, D.R. (1997). Expression of a dominant-negative type II transforming receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition.,, 2386-2391.
  44. Weichenthal, M, Schwarz, T. (2005). Phototherapy, how does UV work?,, 260-266
  45. Widom, R.L. (2000). Regulation of matrix biosynthesis and degradation in systemic sclerosis.,(6), 534-539.
DOI: https://doi.org/10.2478/v10046-011-0022-4 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 80 - 86
Published on: Feb 15, 2012
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2012 Iveta Ivdra, Ilona Hartmane, Ingmars Mikažāns, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.